IGF2BP3-induced activation of EIF5B contributes to progression of hepatocellular carcinoma cells
Open Access
- 1 January 2022
- journal article
- research article
- Published by Tech Science Press in Oncology Research
- Vol. 30 (2) , 77-87
Abstract
In this study, we investigated the functional role of eukaryotic initiation factor 5B (EIF5B) in hepatocellular carcinoma (HCC) and the underlying mechanisms. Bioinformatics analysis demonstrated that the EIF5B transcript and protein levels as well as the EIF5Bcopy number were significantly higher in the HCC tissues compared with the non-cancerous liver tissues. Down-regulation of EIF5B significantly decreased proliferation and invasiveness of the HCC cells. Furthermore, EIF5B knockdown suppressed epithelial-mesenchymal transition (EMT) and the cancer stem cell (CSC) phenotype. Down-regulation of EIF5B also increased the sensitivity of HCC cells to 5-fluorouracil (5-FU). In the HCC cells, activation of the NF-kappa B signaling pathway and IkB phosphorylation was significantly reduced by EIF5B silencing. IGF2BP3 increased the stability of the EIF5B mRNA in an m6A-dependent manner. Our data suggested that EIF5B is a promising prognostic biomarker and therapeutic target in HCC.Keywords
This publication has 20 references indexed in Scilit:
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analysesNucleic Acids Research, 2017
- AASLD guidelines for the treatment of hepatocellular carcinomaHepatology, 2017
- eIF5B increases ASAP1 expression to promote HCC proliferation and invasionOncotarget, 2016
- Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in CancerMolecules, 2016
- Inhibition of mesothelioma cancer stem‐like cells with adenovirus‐mediated NK4 gene therapyInternational Journal of Cancer, 2014
- Upregulation of eIF5B controls cell-cycle arrest and specific developmental stagesProceedings of the National Academy of Sciences, 2014
- Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: Experience of the Bologna Liver Oncology GroupDigestive and Liver Disease, 2014
- Interleukin 23 Promotes Hepatocellular Carcinoma Metastasis via NF-Kappa B Induced Matrix Metalloproteinase 9 ExpressionPLOS ONE, 2012
- [Abnormality of NF- kappa B expression and the clinical implications in patients with HBV-related hepatocellular carcinoma].2011
- Transcriptome-wide Identification of RNA-Binding Protein and MicroRNA Target Sites by PAR-CLIPCell, 2010